Clinicopathologic significance of S 100 A 4 expression in osteosarcoma
暂无分享,去创建一个
C.-M. Cao | P-L Wang | Q-X Yang | F.-X. Yang | X. Sun
[1] Ruolin Li,et al. Clinicopathological and Prognostic Value of S100A4 Expression in Gastric Cancer: A Meta-Analysis , 2014, The International journal of biological markers.
[2] F. T. ten Kate,et al. Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis , 2014, Annals of Surgical Oncology.
[3] Shan Li,et al. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis , 2013, Diagnostic Pathology.
[4] Seung‐Mo Hong,et al. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma , 2013, Journal of Clinical Pathology.
[5] Jun Liang,et al. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma , 2013, The Journal of international medical research.
[6] H. Zhao,et al. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway. , 2012, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[7] Y. Glinka,et al. Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation. , 2012, Biochemical and biophysical research communications.
[8] Xueqiong Zhu,et al. Immunohistochemical expression of Annexin A2 and S100A proteins in patients with bulky stage IB-IIA cervical cancer treated with neoadjuvant chemotherapy. , 2012, Gynecologic oncology.
[9] D. Komura,et al. Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma , 2011, Tumor Biology.
[10] Guoyou Zhang,et al. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[11] Xu Ma,et al. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. , 2010, Cancer letters.
[12] J. Adán,et al. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate , 2010, BMC Cancer.
[13] G. Melloni,et al. Prognostic Factors and Analysis of S100a4 Protein in Resected Pulmonary Metastases from Renal Cell Carcinoma , 2009, World Journal of Surgery.
[14] J. Bovée,et al. Osteosarcoma of the femur with skip, lymph node, and lung metastases. , 2008, Radiographics : a review publication of the Radiological Society of North America, Inc.
[15] D. Helfman,et al. The metastasis associated protein S100A4: role in tumour progression and metastasis , 2005, British Journal of Cancer.
[16] E. Hovig,et al. S100A4 regulates membrane induced activation of matrix metalloproteinase-2 in osteosarcoma cells , 2003, Clinical & Experimental Metastasis.
[17] W. Park,et al. Overexpression of S100A4 is closely related to the aggressiveness of gastric cancer , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[18] L. Mazzucchelli. Protein S100A4: too long overlooked by pathologists? , 2002, The American journal of pathology.
[19] J. Winstanley,et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. , 2000, Cancer research.
[20] O. T. Odegaard,et al. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. , 1999, Cancer research.
[21] Yohko Nakamura,et al. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells , 1997, Oncogene.
[22] E. Hovig,et al. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. , 1996, Cancer research.
[23] P. Rudland,et al. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. , 1993, Oncogene.